Leading Companies - Fluorescence Guided Surgery Systems Industry

Over the course of the projection period, it is anticipated that the global market for fluorescence guided surgery systems would increase in response to the rising prevalence of chronic diseases, such as cancer and heart diseases, around the world. The location and margins of the tumour can be determined throughout the process using fluorescence guided surgery (FGS). The World Health Organisation (WHO) estimates that cancer will be the primary cause of death for over 10 million people worldwide in 2020, or one in every six fatalities. Breast, lung, prostate, colon, and rectum cancers are the most prevalent types of cancer. This is thus anticipated to fuel market expansion. Over the projected period, an increase in the use of cutting-edge imaging techniques is anticipated to boost market expansion for fluorescence guided surgery systems. For instance, FGS is an imaging technology that enables surgeons to see various structures and types of tissue that might not be as evident under white light settings during a surgical procedure.

Coherent Market Insights estimates that the market for Fluorescence Guided Surgery Systems was valued at US$ 67.8 Mn in 2021 and is anticipated to grow at a CAGR of 16.6% between 2022 and 2028 to reach US$ 199.0 Mn.

Top Companies in the Fluorescence Guided Surgery Systems Industry:

PerkinElmer, Inc.

The company was started in 1937 and is based in Waltham, Massachusetts, United States. The primary areas of interest for the company include translational multi-omics technologies, biomarker identification, imaging, forecasting, testing, discovering and identifying, and analytics. PerkinElmer declared that the acquisition of Oxford Immunotec Global PLC had been completed in March 2021. PerkinElmer announced its intention to purchase Horizon Discovery Group in November 2020 for about US$383 million.

Stryker

The company was started in 1941 and is located in Kalamazoo, Michigan, United States. The Stryker Corporation creates, produces, and sells specialised surgical and healthcare products. The corporation announced in January 2022 that it will purchase Vocera Communications, a digital care company, for about $3 billion. Stryker announced in January 2021 that it will buy OrthoSensor, Inc., a joint replacement technology company.

Medtronic

The firm was started in 1949 and is based in Minneapolis, Minnesota. It creates and produces medical treatments and technologies. The business announced its intent to purchase Stimgenics, LLC and their main therapy in January 2020. The company declared in January 2022 that it will buy Affera, Inc. A contract between Medtronic and healthcare performance improvement firm Vizient was revealed in March.

Karl Storz

The company was started in 1945 and is located in Germany, Tuttlingen. The business produces medical equipment and devices. The business sells endoscopic tools for veterinary, industrial, and human medical uses. Modern technology is available from KARL STORZ for minimally invasive operations in almost all surgical disciplines.

Hamamatsu Photonics KK

The business was started in 1953 and is based in Shizuoka, Japan. The business produces semiconductors, image processors, and electron tubes. The company makes photosensitive electronic tubes, optical/image sensors, X-ray and laser-related devices, photodiodes, light-emitting diodes (LED), and video cameras for measurement equipment, among other things.

Shimadzu Corporation

The firm was started in 1875 and is based in Kyoto, Japan. The business creates, produces, and markets analytical and measurement tools, medical systems, as well as industrial and aeronautical equipment. Through its affiliated businesses in Japan, the US, the UK, and China, Shimadzu conducts product research, development, and marketing.

Gentige (Fluoptics)

The company was established in 2009 and has its headquarters in Grenoble, France. The business offers goods and services for life science, sterile reprocessing, operating rooms, cardiology operations, and intensive care.  Getinge announced in April 2022 that it will purchase FLUOPTICS, a pioneer in the field of near infrared imaging technologies. 

Definition:

A medical technology called fluorescence guided surgery (FGS) creates a real-time fluorescence image of the surgical site to help direct the procedure. FGS is much more affordable and simple to use than more common medical imaging methods like CT and MRI, and it can even provide real-time imaging while undergoing surgery.